Abstract Background: Gathered evidence suggested bipolar disorder and unipolar depression are both related to dysregulated inflammatory reaction. Our recent studies found bipolar disorder is with a more severe inflammatory dysregulation than the unipolar depression, with significantly higher levels of pro-inflammatory cytokines, and pro-inflammatory cytokines, esp sTNF-R1, may be potential biomarkers that patients with subtype of bipolar disorder and different mood states. However, few studies investigated the association between pro-inflammatory cytokines and neuroimaging abnormalities in bipolar disorder in literatures. Method: The study subjects were clinically stable patients with bipolar disorder, age from 18 to 65 years. They completed assessments of psychiatric symptoms, pro-inflammatory cytokines, and MRI assessments. Results: In total, 75 patients with bipolar disorder were enrolled, with 64% female and average age of 42.7 ± 10.4 years old. With controlling of age, gender, BMI, intracranial volume, and duration of illness, we found higher level of sTNF-R was associated with reduced grey matter volume over left Crus II、right Crus II, occipital pole, lateral Occipital Cortex, inferior division, planum temporale, supramarginal gyrus, posterior division, and higher level of sIL-6R was associated with reduced cortex thickness over the left middle temporal. Conclusion: Negative correlations were found between level of sTNF-R and grey matter which involve carrying information about body movement between the cortex and the brain stem, auditory and linguistic processing, visual processing center and somatosensory association cortex; as well as the level of sIL-6R and cortex thickness over the left middle temporal, which involve processing sensory input into derived meanings for the appropriate retention of visual memories, language comprehension and emotion association. The results supported that proinflammatory cytokines could be biomarkers for neuroimaging abnormality in bipolar disorder.
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Immune-inflammatory markers: as a potential biomarker for staging bipolar disorder In this study, we evaluated the changes of peripheral immune-inflammatory markers relevant to the clinical course in patients with bipolar disorder to look into the possibility of immune-inflammatory markers as a potential biomarker for staging bipolar disorder(BD).
Method:
Patients with BD and healthy controls were compared to see the abnormalities in peripheral immune-inflammatory markers using TNF-alpha, IL-6, mcp1/ccl2, CRP, BDNF, and Vitamin D. We also evaluated the changes of peripheral immune-inflammatory markers episodically in response to the clinical course and mood states e.g. acute, continuation and maintenance phase. Results: A total of 17 patients with bipolar mania(60%female; mean age 46.8 ± 10.6 years; mean duration of illness 16.2 ± 10.6 years; mean YMRS scores 43.4 ± 4.5; mean MADRS scores 1.8 ± 3.0) and 40 healthy controls (52.6%female; mean age 38.7 ± 14.1years) were enrolled. There were no statistically significant differences between the two groups for sex and age. IL-6 and CRP were consistently increased in BD compared with control group. The result for IL-6 showed that the mean difference is 2.64 ± 0.80 pg/mL(p=0.002) in acute phase and 1.38 ± 0.56 pg/ mL(p=0.018) in maintenance phase. The result for CRP showed that the mean difference is 4.95 ± 1.42 mg/L(p=0.001) in acute phase and 1.33 ± 0.59 mg/L(p=0.028) in maintenance phase. MCP1/CCL2 was changed episodically in response to the clinical course and mood states (359.7 ± 82.3 pg/mL in acute phase, 243.6 ± 66.9 pg/mL in continuation phase, 299.4 ± 81.5 pg/mL in maintenance phase, p=0.002). Conclusion: Our results suggest that immune-inflammatory activity is possible to be correlated with the episodic clinical course of BD. Larger samples of BD should be studied for further investigation.
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Early recognition of bipolar depression 
Results:
The study found that all of the patients reported depression throughout the first episode. Simultaneously, all were initially diagnosed as suffering from unipolar depression. During 5-7 year follow-up observation (mean 6,6 ± 1,2) the recurrent depressive disorder diagnosis was changed to bipolar depression (bipolar II disorder: 296,89-DSM-V; F31.8 -ICD-10) in all of the 43 patients. MDQ revealed at least 1 hypomanic episode in anamnesis of 27 patients (62,8%) of the whole group. There weren't either any manic episodes or any psychotic symptoms diagnosed during the observation period. Conclusions: Accurate retrpospective analysis of all anamnestic data with follow-up observations and self-report screening, such as MDQ, facilitate timely recognition of the beginning of bipolar disorder.
